Alison Long
Director/Miembro de la Junta en TAYSHA GENE THERAPIES, INC. .
Fortuna: 168 825 $ al 31/05/2024
Cargos activos de Alison Long
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director/Miembro de la Junta | 01/11/2023 | - |
| Independent Dir/Board Member | 01/11/2023 | - |
Historial de carrera de Alison Long
Antiguos cargos conocidos de Alison Long.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 15/12/2021 | 01/06/2022 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Director Técnico/Científico/I+D | 01/10/2021 | 01/11/2021 |
Formación de Alison Long.
| University of the Witwatersrand | Doctorate Degree |
| George Mason University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Reino Unido | 2 |
| Sudafrica | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Alison Long
- Experiencia
